Ht Partners LLC Eli Lilly & CO Transaction History

Ht Partners LLC

$276 Million
Q1 2024

A detailed history of Ht Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ht Partners LLC holds 4,250 shares of LLY stock, worth $3.89 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

4,250

Previous 4,204 1.09%

Holding current value

$3.89 Million

Previous $2.45 Million 34.94%

% of portfolio

1.2%

Previous 0.98%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $27,241 - $36,444	46 Added 1.09%	4,250 $3.31 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $14,180 - $16,716	27 Added 0.65%	4,204 $2.45 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $31,298 - $43,149	72 Added 1.75%	4,177 $2.24 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $31,566 - $42,208	-90 Reduced 2.15%	4,105 $1.93 Million
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $23,421 - $26,691	-79 Reduced 1.85%	4,195 $1.36 Million

Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $557 - $654	2 Added 0.05%	4,274 $1.39 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $25,633 - $33,184	-156 Reduced 3.52%	4,272 $798,000
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $7,958 - $10,530	61 Added 1.4%	4,428 $748,000
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $997 - $1,163	-9 Reduced 0.21%	4,367 $484,000
Q1 2019 Apr 08, 2019	BUY	$111.31 - $131.02 $1,001 - $1,179	9 Added 0.21%	4,376 $568,000
Q4 2018 Jan 11, 2019	BUY	$105.9 - $118.64 $63,540 - $71,184	600 Added 15.93%	4,367 $505,000
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $290,322 - $322,229	3,767	3,767 $325,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ht Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ht Partners LLC with notifications on news.

Account